Viewing Study NCT06622434


Ignite Creation Date: 2025-12-25 @ 2:32 AM
Ignite Modification Date: 2026-01-08 @ 5:21 PM
Study NCT ID: NCT06622434
Status: RECRUITING
Last Update Posted: 2025-09-09
First Post: 2024-09-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: New Adjuvant Vaccine in Glioblastoma, a Phase 1/2a Study
Sponsor: Assistance Publique - Hôpitaux de Paris
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-11-08
Start Date Type: ACTUAL
Primary Completion Date: 2027-05-08
Primary Completion Date Type: ESTIMATED
Completion Date: 2027-05-08
Completion Date Type: ESTIMATED
First Submit Date: 2024-09-25
First Submit QC Date: None
Study First Post Date: 2024-10-02
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-09-08
Last Update Post Date: 2025-09-09
Last Update Post Date Type: ESTIMATED